Response from CGB, page-175

To all QBL / CGB Shareholders, there are a number of questions you may want to consider.

1) Why are there 1,212,857,143 shares being paid to MCL?
QBL already had (have) a controlling 55% interest in MCL. 
Purchase of 55% was 49M shares (this was the purchase price). There was a further 50M performance bonus shares if MCL obtained a permit to grow cannabis varieties for medical research leading to product development.

2) Medcan acquisition had an indicative completion date of 23rd October, 2018.

3) Re-quotation (resumption of trade) on ASX - 30th October, 2018.

https://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=01835802